Icon Advisers Inc Edwards Lifesciences Corp Transaction History

Icon Advisers Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 05, 2020	SELL	$67.19 - $87.44 $557,677 - $725,752	-8,300 Closed	0 $0
Q2 2020 Aug 03, 2020	BUY	$57.54 - $76.95 $264,684 - $353,970	4,600 Added 124.32%	8,300 $574,000
Q2 2019 Aug 02, 2019	SELL	$55.74 - $64.41 $323,292 - $373,578	-5,800 Reduced 61.05%	3,700 $684,000
Q1 2019 May 01, 2019	SELL	$47.89 - $64.05 $167,615 - $224,175	-3,500 Reduced 26.92%	9,500 $1.82 Million
Q1 2018 Apr 30, 2018	SELL	$37.19 - $47.45 $364,462 - $465,010	-9,800 Reduced 42.98%	13,000 $1.81 Million
Q4 2017 Feb 06, 2018	SELL	$33.79 - $39.39 $195,982 - $228,462	-5,800 Reduced 20.28%	22,800 $2.57 Million
Q3 2017 Nov 08, 2017	BUY	$36.29 - $38.83 $1.04 Million - $1.11 Million	28,600	28,600 $3.13 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Icon Advisers Inc, based on Form 13F filings with the SEC.

Stay updated on Icon Advisers Inc with notifications on news.